Sun Sentinel Broward Edition

Will meds affect prostate cancer?

- Write to Dr. Roach at ToYourGood­Health@ med.cornell.edu or mail to 628 Virginia Dr., Orlando, FL 32803.

Dear Dr. Roach: I’ve had low-grade prostate cancer for several years and am presently on “active surveillan­ce.” My PSAs have been high but steady. I have a greatly enlarged prostate.

I would like your opinion regarding finasterid­e (Proscar), as I am considerin­g taking it. I see one of its side effects is that it increases the risk of developing a very serious form of prostate cancer. — D.N.W.

A 2013 study showed that although finasterid­e reduced the overall risk of prostate cancer from 15% to 10% in men followed up to 18 years on finasterid­e, there was a small increase in high-grade, aggressive prostate cancer, from 3% to 3.5%. However, there was no increased risk of prostate cancer death among treated men.

Several follow-up studies have suggested that the apparent small increase in aggressive prostate cancers reflected an easier ability to find these cancers. My view is that the apparent increase in aggressive prostate cancer is unlikely to represent a real danger in taking finasterid­e.

Dear Dr. Roach: I have breast cancer and am being recommende­d anastrozol­e. Can you tell me the side effects? — Anon.

Anastrozol­e is an inhibitor of the enzyme aromatase, which converts androgens made in the adrenal gland to estrogens.

Aromatase inhibitors have been used for over 20 years. There are short-term effects, and these limit the ability of some women to tolerate their use.

Symptoms can be severe in up to a third of women taking it, but regular exercise and anti-inflammato­ry drugs are effective in reducing these symptoms.

There are sexual side effects for many women. Estrogen is needed for vaginal health.

Fatigue, forgetfuln­ess and poor sleep are often reported by women on anastrozol­e.

 ??  ??

Newspapers in English

Newspapers from United States